BioAtla | Investor Presentation Deck | 43 slides · page 15 of 43
Includes specific clinical trial data (N=73 and N=26) and detailed breakdown of specific adverse events like constipation, neuropathy, and diarrhea.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 6/6
list 1/1 source-note 1/1 table 2/2 title 2/2
Components 6
bullet source-note data data action-title headline
Tools 2
List presentation slide · 70%
list/bullet: No treatment-related deaths; Few treatment-related SAEs; Very few related AEs leading to discontinuation; No clinically meaningful on-target toxicity; Differentiated profile.
Table data slide · 90%table/data: Specific adverse event grades for constipation, peripheral neuropathy, and diarrhea
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.